Fundraising Fox
Empirico
San Diego, US · Founded 2017 · 7 known investors
Find your way into Empirico
Sign up to see every warm intro you have to Empirico
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Empirico team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Empirico is a San Diego-based clinical-stage biotech that uses human genetics data and computational methods to discover disease targets and develop siRNA and antibody therapeutics.
Founders & leadership
Empirico was founded in 2017 by Omri Gottesman and Shannon Bruse.
Board
Investors · 7
How we know: DCVC (Data Collective)'s portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Felicis Ventures's portfolio page · Not right? Tell us
Also in the syndicate · 2
Funding
SEC filings, press & company announcements$74.8M disclosed across 3 of 5 rounds · 2018–2023
- Undisclosed amountseries A-2Jan 2020
Ionis Pharmaceuticals Inc.
Source ↗
▶$45.2MraisedMar 2023 · 4 investors · BiotechnologyRule 506(b)
- John HamerDirector
- Omri GottesmanExecutive Officer, Director
- Shannon BruseExecutive Officer, Director
- Dennis LangerDirector
- Kolluri SwaroopDirector
- Brian CajesExecutive Officer
- Offering amount
- $55.2M
- Amount sold
- $45.2M
- First sale
- Mar 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$17MraisedDec 2019 · 3 investors · BiotechnologyRule 506(b)
- Omri GottesmanExecutive Officer, Director
- John HamerDirector
- Kolluri SwaroopDirector
- Shannon BruseExecutive Officer, Director
- Brian CajesExecutive Officer
- Offering amount
- $17M
- Amount sold
- $17M
- First sale
- Dec 2019
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$12.5MraisedNov 2018 · 5 investors · BiotechnologyRule 506(b)
- Omri GottesmanExecutive Officer, Director
- John HamerDirector
- Brian CajesExecutive Officer
- Shannon BruseExecutive Officer, Director
- Kolluri SwaroopDirector
- Offering amount
- $12.5M
- Amount sold
- $12.5M
- First sale
- Nov 2018
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Empirico do?
- Empirico is a San Diego-based clinical-stage biotech that uses human genetics data and computational methods to discover disease targets and develop siRNA and antibody therapeutics.
- Who founded Empirico?
- Empirico was founded by Omri Gottesman, Shannon Bruse in 2017.
- Who are Empirico's investors?
- Empirico's investors include DCVC (Data Collective), Felicis Ventures, Qiming Venture Partners USA, DCVC Bio, Qiming Venture Partners.
- How much funding has Empirico raised?
- Empirico has disclosed $74.8M raised across 3 of its 5 known rounds.
- Where is Empirico headquartered?
- Empirico is headquartered in San Diego, US.